Microarray technology encompasses a few relatively well-established methods and numerous applications that are in various stages of development. Apart from their use as a tool for diagnostic ...

Parallel quantification of large numbers of messenger RNA transcripts using microarray technology promises to provide detailed insight into cellular processes involved in the regulation of gene ...

Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication of data supporting the effective use of its high-density microarray patch ...

The global peptide microarray market share analysis is on a steady growth trajectory, projected to reach USD 903.8 million by 2025, with a compound annual growth rate (CAGR) of 3.8%. By 2035, the ...

One of the primary obstacles in microarray-based cancer classification is the disproportionate number of features relative to patient samples, leading to model overfitting and reduced accuracy.

today announced the publication of data supporting the effective use of its high-density microarray patch (HD-MAP) technology to deliver nucleic acid-based vaccines in collaboration with The ...

New data announced by Vaxxas supports the use of its high-density microarray patch (HD-MAP) technology to deliver DNA-based ...

Clinical-stage biotechnology company Vaxxas has announced the publication of data supporting the potential use of its ...

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, ...

Partnership to Deliver More Effective Treatments for Skin-Based and Immune-Mediated Applications Our BioForge collaboration is a key advan ...

Nikon Instruments Inc. today announced the opening of the newest Nikon Center of Excellence at the Moffitt Cancer Center.